Founded in 1978 as the National Neurofibromatosis Foundation, the Children's Tumor Foundation (CTF) is a nonprofit organization committed to identifying effective drug therapies for neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis, and improving the lives of those living with these disorders.
To that end, CTF is inviting applications for the Young Investigator Award. Through the program, salary support of up to $54,000 per year for two years will be awarded to scientists early in their careers. The research scope of the program includes all manifestations of all types of NF (NF1, NF2, schwannomatosis); a subset of the available funds will be dedicated to funding NF2 and schwannomatosis-focused studies, and such proposals will be evaluated separate from NF1-focused proposals to ensure that a minimum number of NF2/schwannomatosis studies can be initiated.
To be eligible, applicants must be a postdoctoral fellow (MD, PhD, or equivalent) no more than seven years past completion of their first doctoral degree or a graduate student pursuing their MD, PhD, or equivalent. Applicant must be affiliated with the laboratory of a senior researcher who can serve as a research sponsor.
Letters of Intent are due January 3, 2020. Upon review, selected applicants will be invited to submit a full application by March 6, 2020.
See the Children's Tumor Foundation website for complete program guidelines and application instructions.